Dimensional Fund Advisors’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
448,162
+185,172
| +70% | +$835K | ﹤0.01% | 2756 |
|
|
2025
Q1 | $1.22M | Buy |
262,990
+118,179
| +82% | +$548K | ﹤0.01% | 2841 |
|
|
2024
Q4 | $1M | Buy |
144,811
+5,538
| +4% | +$38.4K | ﹤0.01% | 2914 |
|
|
2024
Q3 | $738K | Sell |
139,273
-14,485
| -9% | -$76.8K | ﹤0.01% | 2961 |
|
|
2024
Q2 | $575K | Buy |
153,758
+81,083
| +112% | +$303K | ﹤0.01% | 3006 |
|
|
2024
Q1 | $512K | Buy |
72,675
+48,362
| +199% | +$341K | ﹤0.01% | 3038 |
|
|
2023
Q4 | $137K | Sell |
24,313
-12,971
| -35% | -$73.3K | ﹤0.01% | 3245 |
|
|
2023
Q3 | $179K | Buy |
37,284
+16
| +0% | +$77 | ﹤0.01% | 3231 |
|
|
2023
Q2 | $255K | Hold |
37,268
| – | – | ﹤0.01% | 3196 |
|
|
2023
Q1 | $290K | Buy |
+37,268
| New | +$290K | ﹤0.01% | 3128 |
|